Earnings History Data for Surmodics, Inc. (SRDX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Surmodics, Inc.

SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
01-02-2024	PM		SRDX	Surmodics, Inc.	503.39	N/A	-0.35	-0.50	Surmodics beats top-line and bottom-line estimates; updates FY24 outlook [2/1/2024 7:15 AM]	32.47	-2.74 (-7.80%)	0.0	0.0 (0.00%)	16.00 - 39.41	71,554	30,000	0
Surmodics beats top-line and bottom-line estimates; updates FY24 outlook [2/1/2024 7:15 AM]
08-11-2023	PM		SRDX	Surmodics, Inc.	430.52	0.53	0.16	-0.26	Surmodics Non-GAAP EPS of $0.53, revenue of $28M [11/8/2023 7:48 AM]	33.24	2.28 (7.36%)	33.24	0.0 (0.00%)	16.00 - 39.41	58,962	30,000	1,585
Surmodics Non-GAAP EPS of $0.53, revenue of $28M [11/8/2023 7:48 AM]
02-08-2023	PM		SRDX	Surmodics, Inc.	453.28	0.52	-0.46	-0.34	Surmodics Non-GAAP EPS of $0.52 beats by $0.98, revenue of $52.5M beats by $14.44M [8/2/2023 9:05 AM]	32.56	1.38 (4.44%)	32.65	1.47 (4.71%)	16.00 - 39.17	84,524	50,000	2,473
Surmodics Non-GAAP EPS of $0.52 beats by $0.98, revenue of $52.5M beats by $14.44M [8/2/2023 9:05 AM]
26-04-2023	PM	7:00 AM ET (Apr 26)	SRDX	Surmodics, Inc.	333.92	-0.40	-0.48	-0.22	Surmodics Non-GAAP EPS of -$0.40 beats by $0.11, revenue of $27.2M beats by $1.34M [4/26/2023 7:05 AM]	24.10	0.24 (1.01%)	0.0	0.0 (0.00%)	16.00 - 42.34	87,284	80,000	0
Surmodics Non-GAAP EPS of -$0.40 beats by $0.11, revenue of $27.2M beats by $1.34M [4/26/2023 7:05 AM]
06-02-2023	AH	After the close (Feb 6)	SRDX	Surmodics, Inc.	423.21	-0.50	-0.63	-0.13	Surmodics Non-GAAP EPS of -$0.50 beats by $0.16, revenue of $24.9M beats by $0.93M [2/6/2023 4:12 PM]	31.23	1.04 (3.44%)	30.19	0.0 (0.00%)	24.33 - 45.85	47,176	60,000	657
Surmodics Non-GAAP EPS of -$0.50 beats by $0.16, revenue of $24.9M beats by $0.93M [2/6/2023 4:12 PM]
09-11-2022	PM	7:30 AM ET (Nov 9)	SRDX	Surmodics, Inc.	499.98	-0.26	-0.38	-0.10	Surmodics Non-GAAP EPS of -$0.26 beats by $0.19, revenue of $25.99M beats by $1.9M [11/9/2022 7:46 AM]	32.18	-2.14 (-6.24%)	34.32	0.0 (0.00%)	28.27 - 57.71	45,750	30,000	1,352
Surmodics Non-GAAP EPS of -$0.26 beats by $0.19, revenue of $25.99M beats by $1.9M [11/9/2022 7:46 AM] Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance [Nov-09-22 07:00AM]
27-07-2022	PM	7:30 AM ET (Jul 27)	SRDX	Surmodics, Inc.	537.36	-0.34	-0.39	-0.17	Surmodics Non-GAAP EPS of -$0.34 beats by $0.04, revenue of $24.9M misses by $0.29M [7/27/2022 8:50 AM]	35.80	-2.19 (-5.76%)	0.0	0.0 (0.00%)	32.43 - 62.27	44,420	40,000	0
Surmodics Non-GAAP EPS of -$0.34 beats by $0.04, revenue of $24.9M misses by $0.29M [7/27/2022 8:50 AM] Surmodics Reports Third Quarter Fiscal 2022 Results [Jul-27-22 07:30AM]
27-04-2022	PM	7:30 AM ET (Apr 27)	SRDX	Surmodics, Inc.	588.81	-0.22	-0.32	0.62	Surmodics Non-GAAP EPS of -$0.22 beats by $0.12, revenue of $26.1M beats by $2.13M [4/27/2022 7:34 AM]	40.12	-0.27 (-0.67%)	40.39	0.0 (0.00%)	36.24 - 62.27	49,279	30,000	404
Surmodics Non-GAAP EPS of -$0.22 beats by $0.12, revenue of $26.1M beats by $2.13M [4/27/2022 7:34 AM] Pounce Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases [Apr-27-22 07:15AM] Surmodics Reports Second Quarter Fiscal 2022 Results [Apr-27-22 07:30AM] SurModics (SRDX) Reports Q2 Loss, Tops Revenue Estimates [Apr-27-22 08:45AM]
03-02-2022	PM	7:30 AM ET (Feb 3)	SRDX	Surmodics, Inc.	638.39	-0.13	-0.36	0.02	Surmodics Non-GAAP EPS of -$0.13, revenue of $23M; reaffirms full year guidance [2/3/2022 7:39 AM]	40.37	-5.72 (-12.41%)	46.09	0.0 (0.00%)	36.24 - 62.27	146,904	60,000	6,591
Surmodics Non-GAAP EPS of -$0.13, revenue of $23M; reaffirms full year guidance [2/3/2022 7:39 AM] Surmodics hits a 52 week low as Q1 revenue miss expectations [2/3/2022 10:54 AM] Surmodics Reports First Quarter Fiscal 2022 Results [Feb-03-22 07:30AM] SurModics (SRDX) Reports Q1 Loss, Misses Revenue Estimates [Feb-03-22 08:55AM]
10-11-2021	PM	7:30 AM ET (Nov 10)	SRDX	Surmodics, Inc.	790.01	-0.10	-0.25	-0.18	Surmodics EPS beats by $0.15, beats on revenue [11/10/2021 7:48 AM]	50.85	-5.46 (-9.70%)	56.31	0.0 (0.00%)	36.43 - 62.27	149,845	50,000	242
Surmodics EPS beats by $0.15, beats on revenue [11/10/2021 7:48 AM] Surmodics reaches a nine-month low as guidance disappoints [11/10/2021 2:14 PM] Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance [Nov-10-21 07:30AM] SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates [Nov-10-21 08:55AM] Surmodics Inc (SRDX) Q4 2021 Earnings Call Transcript [Nov-10-21 04:31PM]
04-08-2021	PM	7:30 AM ET (Aug 4)	SRDX	Surmodics, Inc.	759.55	-0.17	-0.11	0.21	Surmodics EPS in-line, beats on revenue [8/4/2021 7:42 AM]	54.73	-1.64 (-2.91%)	54.73	0.0 (0.00%)	35.17 - 59.75	48,470	30,000	651
Surmodics EPS in-line, beats on revenue [8/4/2021 7:42 AM] Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance [Aug-04-21 07:30AM] SurModics (SRDX) Reports Q3 Loss, Misses Revenue Estimates [Aug-04-21 08:55AM] Surmodics Inc (SRDX) Q3 2021 Earnings Call Transcript [Aug-04-21 03:01PM]
28-04-2021	PM	7:30 AM ET (Apr 28)	SRDX	Surmodics, Inc.	809.93	0.62	0.60	0.04	Surmodics EPS misses by $0.01, beats on revenue [4/28/2021 7:36 AM]	59.10	0.15 (0.25%)	59.10	0.0 (0.00%)	33.45 - 59.75	37,716	30,000	329
Surmodics EPS misses by $0.01, beats on revenue [4/28/2021 7:36 AM] SurModics, Inc. to Host Earnings Call [Apr-28-21 06:45AM] Surmodics Reports Second Quarter Fiscal 2021 Results and Issues Fiscal 2021 Revenue and EPS Guidance [Apr-28-21 07:30AM] SurModics (SRDX) Beats Q2 Earnings Estimates [Apr-28-21 08:55AM] Surmodics Inc (SRDX) Q2 2021 Earnings Call Transcript [Apr-28-21 01:30PM]
09-02-2021	PM	7:30 AM ET (Feb 9)	SRDX	Surmodics, Inc.	618.84	0.02	-0.06	0.05	Surmodics EPS beats by $0.11, misses on revenue [2/9/2021 7:35 AM]	52.21	6.42 (14.02%)	46.76	0.98 (2.13%)	22.06 - 54.28	115,961	48,618	1,692
Surmodics EPS beats by $0.11, misses on revenue [2/9/2021 7:35 AM] Recap: Surmodics Q1 Earnings [Feb-09-21 07:44AM] Surmodics Reports First Quarter Fiscal 2021 Results [Feb-09-21 07:30AM]
04-11-2020	AH	4:05 PM ET (Nov 4)	SRDX	Surmodics, Inc.	502.33	-0.18	0.01	0.37	Surmodics EPS misses by $0.10, beats on revenue [11/4/2020 5:13 PM]	36.44	-1.92 (-5.01%)	36.44	0.0 (0.00%)	22.06 - 49.00	75,144	36,003	967

05-08-2020	AH	4:05 PM ET (Aug 5)	SRDX	Surmodics, Inc.	643.54	0.21	0.10	0.15	Surmodics EPS beats by $0.02, beats on revenue [8/5/2020 4:23 PM]	46.72	-1.76 (-3.64%)	48.48	0.0 (0.00%)	22.06 - 49.00	41,278	63,305	1,794